Meloxicam is a prescription-strength anti-inflammatory that works at surprisingly low doses. Where you might take 400 to 800 mg of ibuprofen several times a day, meloxicam delivers comparable pain relief at just 7.5 to 15 mg taken once daily. That milligram-for-milligram potency, combined with a long duration of action, is what makes it a go-to prescription for chronic joint pain.
How Meloxicam Compares to Over-the-Counter Options
The most useful way to understand meloxicam’s strength is to compare it to the NSAIDs you can buy without a prescription. Ibuprofen tops out at 1,200 mg per day for OTC use (and up to 3,200 mg under medical supervision). Naproxen’s OTC ceiling is around 660 mg daily. Meloxicam achieves its maximum approved effect at just 15 mg once a day. That doesn’t mean 15 mg of meloxicam is “stronger” in a simple sense. It means the drug is far more potent per milligram, so you need much less of it to get a therapeutic effect.
In clinical trials for osteoarthritis, patients taking meloxicam at doses as low as 5 mg daily saw meaningful reductions in pain, stiffness, and physical function over 12 weeks. At the standard 7.5 mg dose, it performs similarly to celecoxib (Celebrex) at 200 mg daily for pain relief and stiffness. Both outperformed acetaminophen for reducing stiffness in at least one head-to-head trial.
Why It Only Needs to Be Taken Once a Day
Meloxicam has a long half-life of roughly 20 hours, meaning it takes that long for your body to clear half of each dose. Peak blood levels arrive about 5 to 6 hours after you take a tablet with food. That slow buildup and slow clearance keep drug levels relatively steady throughout the day, which is why one pill covers a full 24 hours. For comparison, ibuprofen’s half-life is only about 2 hours, which is why it needs to be taken every 4 to 6 hours.
This pharmacology also explains one of the most common complaints about meloxicam: it doesn’t kick in quickly. It takes several days of consistent daily dosing to reach its full anti-inflammatory effect. That makes it a poor choice for a sudden headache or a one-time muscle pull, but well suited for ongoing conditions like osteoarthritis or rheumatoid arthritis, where you need reliable around-the-clock control.
Its COX-2 Preference and What That Means for You
All NSAIDs work by blocking enzymes called COX-1 and COX-2. COX-2 drives inflammation and pain. COX-1 protects the stomach lining and supports other housekeeping functions. Traditional NSAIDs like ibuprofen and naproxen block both roughly equally, which is why they can irritate the stomach.
Meloxicam preferentially targets COX-2 over COX-1, with a selectivity ratio of about 3 to 4. That’s enough to offer some stomach-sparing benefit, but it’s far less selective than a true COX-2 inhibitor like celecoxib (which has a much higher ratio). For this reason, pharmacologists often call meloxicam “COX-2 preferential” rather than “COX-2 selective.” The practical takeaway: it’s generally gentler on the gut than ibuprofen or naproxen, but it isn’t risk-free, especially at higher doses or with long-term use.
GI and Cardiovascular Risk Profile
At the 7.5 mg daily dose, meloxicam carries a 0.03% risk of serious upper gastrointestinal events like bleeding or perforation. That rate is significantly lower than what’s seen with diclofenac, naproxen, or piroxicam. At 15 mg daily, that advantage narrows and only remains statistically significant compared to piroxicam. Doses above 15 mg (22.5 mg and higher) have been linked to a meaningfully increased risk of serious GI events, which is why the FDA caps the daily dose at 15 mg.
On the cardiovascular side, meloxicam’s risk of blood clot-related events like heart attack or stroke was lower than diclofenac’s in large observational data, and similar to naproxen’s and piroxicam’s. This is consistent with what’s known about the entire NSAID class: all of them carry some cardiovascular risk with prolonged use, and meloxicam is no exception, though it doesn’t appear to be worse than most alternatives.
Standard Doses and the Ceiling
For both osteoarthritis and rheumatoid arthritis, the recommended starting dose is 7.5 mg once daily. If that doesn’t provide enough relief, the dose can be increased to 15 mg once daily. That 15 mg ceiling is firm. There is no clinical scenario where exceeding it is considered appropriate, because the risks climb without a proportional increase in benefit.
Some people feel adequately controlled at 7.5 mg and never need to go higher. Others need the full 15 mg. If 15 mg isn’t enough, the typical next step is switching to a different class of medication rather than pushing the dose further.
What to Realistically Expect
You’ll likely notice some pain relief within the first day or two, but the full anti-inflammatory benefit builds over several days of consistent use. In the 12-week osteoarthritis trial, patients on meloxicam saw pain scores drop by about 35% from baseline, compared to roughly 26% for placebo. That’s a real and noticeable difference, though it also means meloxicam reduces pain rather than eliminating it entirely.
Meloxicam works best for the kind of steady, daily aching and stiffness that comes with arthritis. It’s less effective for sharp, sudden pain because of its slow onset. If you’re expecting the fast relief you get from popping two ibuprofen, you’ll be disappointed on day one. The tradeoff is that you only take it once, it lasts all day, and it’s generally easier on the stomach at standard doses.